Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Wilm's Tumor: An Update.

G J D'Angio1, J B Beckwith2, N E Breslow

  • 1Children's Hospital of Philadelphia, Philadelphia, PA.

Cancer
|April 1, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Opting into breast screening over the age of 70 years: seeking evidence to support informed choice.

Clinical radiology·2022
Same author

Molecular regulation of striatal development: a review.

Anatomy research international·2012
Same author

Maternal high-fat diet impacts endothelial function in nonhuman primate offspring.

International journal of obesity (2005)·2012
Same author

The prognostic significance of computerised tomography findings in women with liver metastases from breast cancer.

Breast (Edinburgh, Scotland)·2011
Same author

The transcobalamin (TCN2) 776C>G polymorphism affects homocysteine concentrations among subjects with low vitamin B(12) status.

European journal of clinical nutrition·2010
Same author

Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.

Statistics in medicine·2009
Same journal

Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

Cancer·2026
Same journal

Proliferative ecotype determines lethal prognosis and therapeutic benefit in urothelial carcinoma.

Cancer·2026
Same journal

Reply to "Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer".

Cancer·2026
Same journal

Pediatric cancer survival in the United States from 2001 to 2021.

Cancer·2026
Same journal

Updates on intratumoral therapies in melanoma.

Cancer·2026
Same journal

Correction to "Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025".

Cancer·2026
See all related articles

Wilms' tumor treatment has significantly improved survival rates through collaborative research and refined therapies. This progress minimizes complications, especially crucial for children undergoing chemo- and radiotherapy.

Area of Science:

  • Pediatric Oncology
  • Cancer Treatment Research

Background:

  • Wilms' tumor treatment has historically faced challenges with high mortality rates.
  • Early therapeutic approaches often resulted in significant short- and long-term complications for pediatric patients.
  • Advances in cancer treatment require institutional collaboration for validation and broader application.

Purpose of the Study:

  • To highlight the progress in Wilms' tumor management.
  • To emphasize the importance of cooperative research in advancing cancer therapies.
  • To demonstrate the benefits of refined treatment protocols in pediatric oncology.

Main Methods:

  • Development of treatment methods by single institutions.
  • Confirmation and extension of these methods by national cooperating groups.

Related Experiment Videos

  • Integration of multi-specialist efforts in cancer management studies.

    • Main Results:

    • Significant improvement in survival rates for Wilms' tumor.
    • Refinement of therapy allowing reduced treatment for early-stage disease.
    • Decreased incidence of short- and long-term complications in pediatric patients.

    Conclusions:

    • Collaborative research and integrated studies are vital for advancing cancer treatment.
    • Modern management has transformed Wilms' tumor from a high-mortality disease to a high-survival outcome.
    • Reduced treatment intensity, when feasible, is critical for mitigating treatment-related toxicities in children.